View More Recent Stories

Jun 4, 2018 07:35AM Motus GI Presents Cost Analysis Data Demonstrating Pure-Vu® System Has the Potential to Reduce Costs and Incidence of Colorectal Cancer at Digestive Disease Week® 2018
May 23, 2018 07:35AM Motus GI Enrolls First Patient in REDUCE Study of the Pure-Vu® System in Hospitalized Patients
May 21, 2018 07:35AM Motus GI Announces Issuance of Chinese Patent for the Pure-Vu® System
May 15, 2018 07:35AM Motus GI Reports 2018 First Quarter Financial Results and Provides Business Update
May 10, 2018 08:05AM Motus GI to Present Data at Digestive Disease Week® 2018 Showing Pure-Vu® System May Reduce Costs and Incidence of Colorectal Cancer
Apr 16, 2018 08:05AM Motus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAF
Mar 29, 2018 07:05AM Motus GI Announces 2017 Financial Results and Provides Business Outlook
Mar 27, 2018 07:35AM Motus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® System
Mar 20, 2018 08:05AM Motus GI Announces Issuance of European Patent for the Pure-Vu® System
Mar 13, 2018 08:35AM Motus GI to Present at the Oppenheimer 28th Annual Healthcare Conference
Feb 27, 2018 07:30AM Motus GI Holdings (MOTS) Receives CE Mark Approval for the Pure-Vu System
Feb 27, 2018 07:30AM Motus GI Receives CE Mark Approval for the Pure-Vu® System
Feb 16, 2018 12:00PM Motus GI Holdings, Inc. (Nasdaq: MOTS) to Ring The Nasdaq Stock Market Closing Bell
View More Recent Stories